↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

151 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   Abelmoschus manihot   -   -   -   -   1件:
66 
 2   Ace inhibitor   -   -   -   -   1件:
66 
 3   Ace inhibitor or angiotensin receptor antagonist   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
66 
 4   Ace/arb   -   -   -   -   1件:
66 
 5   Acei   -   -   -   -   2件:
66,
224 
 6   Acei/arb and corticosteroids   -   -   -   -   1件:
66 
 7   Acteoside   Acteoside   -   -   -   1件:
66 
 8   Acth   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   5件:
13,
66,
145,
193,
222 
 9   Acth (acthar) gel   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
66 
 10   Acthar 80 unit injection   -   -   -   -   1件:
66 
 11   Aliskiren   Aliskiren   D03208   1件: REN   2件: Renin secretion, Renin-angiotensin system   3件:
66,
167,
222 
 12   Allopurinol   Allopurinol   D00224   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97 
 13   Angiotensin   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   7件:
17,
19,
46,
66,
86,
222,
224 
 14   Angiotensin blockade   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
66 
 15   Angiotensin ii   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   2件:
66,
222 
 16   Apl-2   -   -   -   -   5件:
61,
62,
66,
222,
223 
 17   Atacicept   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
49,
66 
 18   Atacicept 150 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 19   Atacicept 25 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
13,
66 
 20   Atacicept 75 mg   Atacicept   D09704   2件: TNFSF13, TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   3件:
13,
49,
66 
 21   Atacicept150mg   -   -   -   -   1件:
66 
 22   Atacicept25mg   -   -   -   -   1件:
66 
 23   Atacicept75mg   -   -   -   -   1件:
66 
 24   Atg-f   -   -   -   -   1件:
66 
 25   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 26   Bardoxolone   Bardoxolone   D09584   -   -   7件:
66,
67,
84,
85,
86,
218,
222 
 27   Bardoxolone methyl   Bardoxolone methyl   D09585   -   -   7件:
66,
67,
84,
85,
86,
218,
222 
 28   Bardoxolone methyl capsules   Bardoxolone methyl   D09585   -   -   4件:
66,
67,
86,
222 
 29   Betaloc   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
66 
 30   Bion-1301 multiple doses   -   -   -   -   1件:
66 
 31   Bion-1301 single dose   -   -   -   -   1件:
66 
 32   Blisibimod   Blisibimod   D10311   -   -   5件:
43,
44,
49,
63,
66 
 33   Blood sample   -   -   -   -   12件:
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 34   Bortezomib   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 35   Bortezomib (velcade®)   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   1件:
66 
 36   Budesonide   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   9件:
66,
93,
94,
95,
96,
97,
98,
228,
299 
 37   Calcitriol   Calcitriol   D00129   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   8件:
37,
46,
49,
66,
96,
158,
235,
326 
 38   Ccx168   -   -   -   -   6件:
43,
44,
66,
109,
222,
223 
 39   Cemdisiran   -   -   -   -   2件:
66,
109 
 40   Chinese herb prescription granule plus prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 41   Cilazapril   Cilazapril   D01069, D07699   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   1件:
66 
 42   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 43   Corticotherapy   -   -   -   -   1件:
66 
 44   Cyclophosphamid   Cyclophosphamide   D00287, D07760   -   -   1件:
66 
 45   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 46   Dipyridamole   Dipyridamole   D00302   2件: PDE4A, PDE5A   6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
46,
49,
51,
66,
224 
 47   Enalapril   Enalapril   D00621, D07892   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   4件:
19,
46,
66,
113 
 48   Enalapril valsartan methylprednisone   Methylprednisone   -   -   -   1件:
66 
 49   Fecal microbiota transplantation   -   -   -   -   5件:
2,
66,
94,
96,
97 
 50   Fish oil   Fish oil   -   -   -   7件:
13,
46,
49,
66,
96,
260,
299 
 51   Fostamatinib   Fostamatinib   D09347   1件: SYK   15件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   4件:
46,
49,
61,
66 
 52   Fostamatinib 100 mg   Fostamatinib   D09347   1件: SYK   15件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   1件:
66 
 53   Fostamatinib 150 mg   Fostamatinib   D09347   1件: SYK   15件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   1件:
66 
 54   Fostamatinib disodium tablet 100 mg   Fostamatinib   D09347   1件: SYK   15件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   1件:
66 
 55   Fostamatinib disodium tablet 150 mg   Fostamatinib   D09347   1件: SYK   15件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   1件:
66 
 56   Gastrus   -   -   -   -   1件:
66 
 57   Hormone (prednisone)   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 58   Human soluble recombinant fc-gamma receptor iib   -   -   -   -   1件:
66 
 59   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 60   Hydroxychloroquine sulfate   Hydroxychloroquine   D08050   -   -   2件:
46,
66 
 61   Immunosuppressive agents   -   -   -   -   2件:
50,
66 
 62   Immunosuppressive treatment   -   -   -   -   1件:
66 
 63   Inhibace/cozaar   -   -   -   -   1件:
66 
 64   Intravenous rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
66 
 65   Ionis-fb-lrx   -   -   -   -   1件:
66 
 66   Irbesartan   Irbesartan   D00523   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   4件:
66,
167,
168,
222 
 67   Irbesartan tablets   Irbesartan   D00523   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   2件:
66,
222 
 68   Irbesartan tablets (approved in the usa. reference listed drug avapro) ndc # 43547-0374-03   Irbesartan   D00523   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   2件:
66,
222 
 69   Leflunomide   Leflunomide   D00749   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   9件:
11,
40,
46,
49,
53,
66,
224,
271,
300 
 70   Leflunomide 20 mg+prednisone 0.5mg/kg/d   Leflunomide   D00749   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
66 
 71   Lisinopril   Lisinopril   D00362, D08131   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   5件:
46,
66,
67,
113,
222 
 72   Lnp023   -   -   -   -   3件:
62,
66,
222 
 73   Losartan   Losartan   D00357, D08146   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 74   Low antigen content diet   -   -   -   -   1件:
66 
 75   Menatetrenone   Menatetrenone   D00100   -   -   1件:
66 
 76   Methylprednisolon   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   4件:
13,
51,
66,
222 
 77   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 78   Methylprednisolone (mp) or prednisone (pred)   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 79   Methylprednisolone mylan générique   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 80   Methylprednisolone pulse   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
66,
220 
 81   Methylprednisolone(intravenously in the 1st-2nd-3rd month )   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 82   Methylprednisolone(intravenously in the 1st-3rd-5th month)   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 83   Methylprednisone   Methylprednisone   -   -   -   3件:
46,
66,
222 
 84   Mizoribine   Mizoribine   D01392   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   7件:
49,
51,
53,
66,
94,
222,
224 
 85   Multi-glycoside of tripterygium wilfordii hook. f. (twh)   Tripterygium wilfordii whole   -   -   -   1件:
66 
 86   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 87   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 88   Mycophenolate mofetil (mmf)   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   4件:
49,
60,
66,
222 
 89   Mycophenolate mofetil plus lower dose of prednisone   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
66 
 90   Mycophenolate sodium   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   3件:
53,
66,
222 
 91   Mycophenolic acid   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   7件:
11,
49,
51,
60,
66,
96,
222 
 92   Mycophenolic sodium   -   -   -   -   2件:
66,
222 
 93   Myfortic   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   4件:
49,
66,
222,
228 
 94   Myfortic 180mg tablets   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
66,
222 
 95   Myfortic 360mg tablets   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
66,
222 
 96   Nefecon   -   -   -   -   1件:
66 
 97   Omega-3   Omega-3 fatty acids   -   -   -   7件:
13,
46,
49,
66,
79,
96,
299 
 98   Omega-3 fatty acid   Omega-3 fatty acids   -   -   -   2件:
46,
66 
 99   Omega-3 fatty acid ethylester90   Omega-3 fatty acids   -   -   -   1件:
66 
 100   Omega-3 fatty acid fish oil supplement   Fish oil   -   -   -   1件:
66 
 101   Oms721   -   -   -   -   5件:
64,
66,
109,
222,
223 
 102   Opl-ccl2-lpm   -   -   -   -   1件:
66 
 103   Over-encapsulated 150 mg irbesartan tablets   Irbesartan   D00523   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
66 
 104   Over-encapsulated irbesartan tablets   Irbesartan   D00523   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   2件:
66,
222 
 105   Paricalcitol   Paricalcitol   D00930   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   3件:
19,
66,
218 
 106   Placebo   -   -   -   -   20件:
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 107   Potassium   Potassium   D08403   -   -   9件:
46,
66,
67,
98,
115,
167,
179,
215,
235 
 108   Prednisolon   -   -   -   -   4件:
46,
66,
96,
97 
 109   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 110   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 111   Prednisone + inhibace/cozaar   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 112   Prednisone 5 mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
46,
66 
 113   Prednisone alone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
11,
66 
 114   Prednisone and cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   1件:
66 
 115   Prednisone arrow 20mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 116   Prednisone arrow 5 mg   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 117   Prednisone in full dose   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 118   Prednisone or prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
66 
 119   Prednisone plus cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   1件:
66 
 120   Probucol   Probucol   D00476   -   -   1件:
66 
 121   Protectis   -   -   -   -   1件:
66 
 122   Ramipril   Ramipril   D00421   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   7件:
46,
49,
66,
67,
113,
218,
257 
 123   Rapamune   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   5件:
2,
60,
66,
67,
158 
 124   Re-021   -   -   -   -   2件:
66,
222 
 125   Reh-acteoside   Acteoside   -   -   -   1件:
66 
 126   Renin angiotensin system (ras) blockade   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
66 
 127   Risedronate   Risedronic acid   D00942, D03234, D08484   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   5件:
46,
66,
96,
113,
274 
 128   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 129   Simulect   Basiliximab   D03058   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   2件:
66,
97 
 130   Simvastatin   Simvastatin   D00434   1件: HMGCR   4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 131   Sirolimus   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 132   Sm101   -   -   -   -   3件:
49,
63,
66 
 133   Sparsentan   Sparsentan   -   -   -   2件:
66,
222 
 134   Steroids   -   -   -   -   7件:
46,
50,
51,
63,
66,
96,
97 
 135   Steroids plus azathioprine   Azathioprine   D00238, D03033   -   -   1件:
66 
 136   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 137   Supportive and immunosuppressive therapy   -   -   -   -   1件:
66 
 138   Supportive therapy   -   -   -   -   1件:
66 
 139   Supportive therapy with: ace-inhibitor / arb / statin   -   -   -   -   1件:
66 
 140   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 141   Tailored diet   -   -   -   -   1件:
66 
 142   Telmisartan   Telmisartan   D00627   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   2件:
66,
67 
 143   The yi-qi-qing-jie herbal compound   -   -   -   -   1件:
66 
 144   Tripterygium   Tripterygium wilfordii whole   -   -   -   8件:
46,
66,
67,
96,
162,
222,
224,
271 
 145   Tripterygium wilfordii   Tripterygium wilfordii whole   -   -   -   6件:
46,
66,
67,
222,
224,
271 
 146   Tripterygium wilfordii (tw)   Tripterygium wilfordii whole   -   -   -   2件:
66,
222 
 147   Valsartan   Valsartan   D00400   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   6件:
57,
58,
66,
75,
218,
222 
 148   Vis649   -   -   -   -   1件:
66 
 149   Warfarin   Warfarin   D00564, D01280, D08682   2件: NQO1, VKORC1   5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   10件:
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 150   Wm (shentong granules)   -   -   -   -   1件:
66 
 151    lnp023 hydrochloride salt   -   -   -   -   2件:
62,
66 

先頭へ